The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Slavitt Andrew M since 2010.
This trader's CIK number is 1411209.
At the time of last reporting, Slavitt Andrew M was the Director of Neuehealth, Inc.. (stock ticker symbol NEUE).
Also see all insider trading activities at Neuehealth, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NEUE | 0 | $0 | 0 | $0 | 10,500 | $0 |
| 2024 | NEUE | 0 | $0 | 0 | $0 | 4,755 | $0 |
| 2023 | NEUE | 0 | $0 | 0 | $0 | 95,109 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | CPLA | 0 | $0 | 11,300 | $630,641 | 13,143 | $516,900 |
| 2013 | CPLA | 0 | $0 | 875 | $38,415 | 3,033 | $0 |
| 2012 | CPLA | 0 | $0 | 300 | $10,956 | 919 | $0 |
| 2011 | CPLA | 0 | $0 | 0 | $0 | 555 | $0 |
| 2010 | CPLA | 0 | $0 | 0 | $0 | 350 | $0 |
2. Capella Education Co (CPLA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-13 | NEUE | Option Ex | 10,500 | .00 | 0 |
| 2024-05-12 | NEUE | Option Ex | 4,755 | .00 | 0 |
| 2023-05-13 | BHG | Option Ex | 95,109 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-06-06 | CPLA | Option Ex | 10,000 | 51.69 | 516,900 |
| 2014-06-06 | CPLA | Sale | 11,300 | 55.81 | 630,641 |
| 2014-05-01 | CPLA | Option Ex | 3,143 | .00 | 0 |
| 2013-05-30 | CPLA | Sale | 875 | 43.90 | 38,415 |
| 2013-05-01 | CPLA | Option Ex | 3,033 | .00 | 0 |
| 2012-09-14 | CPLA | Sale | 300 | 36.52 | 10,956 |
| 2012-05-22 | CPLA | Option Ex | 350 | .00 | 0 |
| 2012-05-01 | CPLA | Option Ex | 569 | .00 | 0 |
| 2011-05-23 | CPLA | Option Ex | 350 | .00 | 0 |
| 2011-05-02 | CPLA | Option Ex | 205 | .00 | 0 |
| 2010-05-24 | CPLA | Option Ex | 350 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Slavitt Andrew M (Director of Neuehealth, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.